Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015519:Bone Density / Q000187:drug effects*; D001851:Bone Diseases, Metabolic / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D019587:Dietary Supplements; D004311:Double-Blind Method; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control; D006801:Humans; D008875:Middle Aged; D015675:Osteocalcin / Q000378:metabolism; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control; D017698:Postmenopause; D016896:Treatment Outcome; D014807:Vitamin D / Q000031:analogs & derivatives / Q000097:blood; D014812:Vitamin K / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D010837:Vitamin K 1 / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D024482:Vitamin K 2 / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D014815:Vitamins / Q000008:administration & dosage / Q000627:therapeutic use
D014815:Vitamins; D015675:Osteocalcin; D024482:Vitamin K 2; D014812:Vitamin K; D014807:Vitamin D; D010837:Vitamin K 1; C104450:25-hydroxyvitamin D